Correlates of myalgia in electroconvulsive therapy
Keith G Rasmussen1, Kristin N Petersen, Jessica L Sticka
1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA. rasmussen.keith@mayo.edu
The Journal of ECT
|April 2, 2008
Summary
Muscle pain after electroconvulsive therapy (ECT) is common. This study found that neither seizure activity nor succinylcholine dose affects ECT-induced myalgias, suggesting dose adjustments are unlikely to help.
Area of Science:
- Neuroscience
- Anesthesiology
- Psychiatry
Background:
- Myalgias (muscle pain) are a frequent adverse effect of electroconvulsive therapy (ECT).
- The underlying mechanisms contributing to ECT-induced myalgias remain unclear.
- Two primary hypotheses involve motor activity during seizures and succinylcholine-induced fasciculations.
Purpose of the Study:
- To investigate the correlation between motor activity during ECT-induced seizures and succinylcholine-induced fasciculations with subsequent myalgia complaints.
- To determine if adjusting succinylcholine dosage could mitigate myalgias in ECT patients.
Main Methods:
- Quantified the degree of motor movements during ECT seizures.
- Assessed the intensity of fasciculations caused by succinylcholine administration.
- Correlated these measures, along with succinylcholine dose, with patient-reported myalgia severity.
Main Results:
- No significant correlation was found between the degree of motor activity during seizures and myalgia severity.
- The strength of succinylcholine-induced fasciculations did not correlate with myalgia complaints.
- Succinylcholine dosage itself did not show a correlation with the incidence or severity of myalgias.
Conclusions:
- Neither seizure-related motor activity nor succinylcholine fasciculations appear to be the primary drivers of myalgias following ECT.
- Adjusting succinylcholine dosage is unlikely to be an effective strategy for managing myalgias in patients undergoing ECT.
Related Concept Videos
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

